OC.10.5: THE EFFECT OF PREVALENCE OF LIVER FIBROSIS STAGES IN PERFORMANCE OF NONINVASIVE FIBROSIS BIOMARKERS IN CHRONIC LIVER DISEASES (CLDS): RESULTS OF AN INDEPENDENT, INTERNATIONAL STUDY